NLRP3 and Hypertension: Taken together, our data suggest that renal ELA exerts its beneficial roles in DOCA/salt-induced hypertension via blocking NADPH oxidase/ROS/NLRP3 inflammasome pathway, which is independent on its endogenous receptor APJ.